cis-Diamminedichloroplatinum(II) given in low-dose continuous infusion with concurrent radiotherapy to patients affected by inoperable lung carcinoma: a pharmacokinetic approach View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1998-02

AUTHORS

Franca Morazzoni, Carmen Canevali, Massimo Zucchetti, Sergio Caroli, Alessandro Alimonti, Francesco Petrucci, Gabriella Giudice, Enrico Masoni, Amedeo Vittorio Bedini

ABSTRACT

The pharmacokinetics of cis-diamminedichloro platinum(II) (cisplatin), given as a continuous infusion with concurrent radiotherapy to patients with locally advanced inoperable non-small-cell lung carcinoma, was investigated in 16 cases. The regimen, repeated for 6 consecutive weeks, consisted of weekly 10-Gy radiotherapy given in five fractions from Monday to Friday, and concurrent 100-h infusion of cisplatin delivered at a daily dose of 4 mg/m2 by a central venous catheter and a portable pump. Throughout the weeks of therapy the platinum levels were determined in plasma and in ultrafiltered plasma by respectively inductively coupled plasma atomic emission spectrometry and inductively coupled plasma mass spectrometry. Mean levels of platinum in plasma ([Pt]tot ) increased from the 1st to the 6th week of infusion, while mean levels of platinum in ultrafiltered plasma ([Pt]uf), 110 microg/l, showed no marked variation throughout the therapy. [Pt]uf ranged from 16% to 22% of the total Pt. Mean levels of Pt in ultrafiltered plasma were of the same order of magnitude as those found to be active in vitro as radiopotentiators. Pt decay levels were measured for 24 h at the end of the 1st and 5th weeks of infusion, allowing the calculation of the Pt half-life and the area under the decay curves. The mean value of the area under the decay curve, plotting [Pt]tot against time (AUC), in the range 0-24 h from the end of the 5th week of infusion, was about twice that from the end of the 1st week; by contrast, the mean AUC values did not vary for the [Pt]uf against time curves. The mean values of the alpha half-life of Pt in the ultrafiltered plasma were in accordance with those published in the literature; however, an unexpected very long beta half-life was found (more than 100 h). Thus it was suggested that Pt species other than free cisplatin were present in the ultrafiltered plasma; such species probably involve metal bound to low-molecular-mass proteins. Throughout the therapy, the toxic effects in all patients were negligible, and 75% of them had an objective locoregional reduction of disease. In only 2 cases was progression of disease observed within the irradiated area. On the basis of these data, it can be concluded that cisplatin at a level of 110 microg/l in the ultrafiltered plasma, in the reported scheme of continuous intravenous infusion, has an enhancing effect on radiation and avoids concentration peaks of platinum not bound to protein. More... »

PAGES

37-43

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s004320050131

DOI

http://dx.doi.org/10.1007/s004320050131

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1046233188

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/9498833


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0202", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Atomic, Molecular, Nuclear, Particle and Plasma Physics", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/02", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Physical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Non-Small-Cell Lung", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cisplatin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lung Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Milan", 
          "id": "https://www.grid.ac/institutes/grid.4708.b", 
          "name": [
            "Dipartimento di Scienza dei Materiali, Universit\u00e0 di Milano, Via Emanueli 15, 20126 Milano, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Morazzoni", 
        "givenName": "Franca", 
        "id": "sg:person.01255100453.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255100453.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Milan", 
          "id": "https://www.grid.ac/institutes/grid.4708.b", 
          "name": [
            "Dipartimento di Scienza dei Materiali, Universit\u00e0 di Milano, Via Emanueli 15, 20126 Milano, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Canevali", 
        "givenName": "Carmen", 
        "id": "sg:person.0751665324.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751665324.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mario Negri Institute for Pharmacological Research", 
          "id": "https://www.grid.ac/institutes/grid.4527.4", 
          "name": [
            "Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, Via Eritrea 62, 20157 Milano, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zucchetti", 
        "givenName": "Massimo", 
        "id": "sg:person.0720105551.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720105551.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Superiore di Sanit\u00e0", 
          "id": "https://www.grid.ac/institutes/grid.416651.1", 
          "name": [
            "Laboratorio di Tossicologia Applicata, Istituto Superiore di Sanit\u00e0, Viale Regina Elena 299, 00161 Roma, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Caroli", 
        "givenName": "Sergio", 
        "id": "sg:person.01067474735.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067474735.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Superiore di Sanit\u00e0", 
          "id": "https://www.grid.ac/institutes/grid.416651.1", 
          "name": [
            "Laboratorio di Tossicologia Applicata, Istituto Superiore di Sanit\u00e0, Viale Regina Elena 299, 00161 Roma, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Alimonti", 
        "givenName": "Alessandro", 
        "id": "sg:person.01247677103.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247677103.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Superiore di Sanit\u00e0", 
          "id": "https://www.grid.ac/institutes/grid.416651.1", 
          "name": [
            "Laboratorio di Tossicologia Applicata, Istituto Superiore di Sanit\u00e0, Viale Regina Elena 299, 00161 Roma, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Petrucci", 
        "givenName": "Francesco", 
        "id": "sg:person.01065335303.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01065335303.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Nazionale dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.417893.0", 
          "name": [
            "Istituto Nazionale Tumori, Via Venezian 1, 20133 Milano, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Giudice", 
        "givenName": "Gabriella", 
        "id": "sg:person.0652707500.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652707500.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Milan", 
          "id": "https://www.grid.ac/institutes/grid.4708.b", 
          "name": [
            "Dipartimento di Scienza dei Materiali, Universit\u00e0 di Milano, Via Emanueli 15, 20126 Milano, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Masoni", 
        "givenName": "Enrico", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Nazionale dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.417893.0", 
          "name": [
            "Istituto Nazionale Tumori, Via Venezian 1, 20133 Milano, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bedini", 
        "givenName": "Amedeo Vittorio", 
        "id": "sg:person.01035226740.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01035226740.01"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1998-02", 
    "datePublishedReg": "1998-02-01", 
    "description": "The pharmacokinetics of cis-diamminedichloro platinum(II) (cisplatin), given as a continuous infusion with concurrent radiotherapy to patients with locally advanced inoperable non-small-cell lung carcinoma, was investigated in 16 cases. The regimen, repeated for 6 consecutive weeks, consisted of weekly 10-Gy radiotherapy given in five fractions from Monday to Friday, and concurrent 100-h infusion of cisplatin delivered at a daily dose of 4 mg/m2 by a central venous catheter and a portable pump. Throughout the weeks of therapy the platinum levels were determined in plasma and in ultrafiltered plasma by respectively inductively coupled plasma atomic emission spectrometry and inductively coupled plasma mass spectrometry. Mean levels of platinum in plasma ([Pt]tot ) increased from the 1st to the 6th week of infusion, while mean levels of platinum in ultrafiltered plasma ([Pt]uf), 110 microg/l, showed no marked variation throughout the therapy. [Pt]uf ranged from 16% to 22% of the total Pt. Mean levels of Pt in ultrafiltered plasma were of the same order of magnitude as those found to be active in vitro as radiopotentiators. Pt decay levels were measured for 24 h at the end of the 1st and 5th weeks of infusion, allowing the calculation of the Pt half-life and the area under the decay curves. The mean value of the area under the decay curve, plotting [Pt]tot against time (AUC), in the range 0-24 h from the end of the 5th week of infusion, was about twice that from the end of the 1st week; by contrast, the mean AUC values did not vary for the [Pt]uf against time curves. The mean values of the alpha half-life of Pt in the ultrafiltered plasma were in accordance with those published in the literature; however, an unexpected very long beta half-life was found (more than 100 h). Thus it was suggested that Pt species other than free cisplatin were present in the ultrafiltered plasma; such species probably involve metal bound to low-molecular-mass proteins. Throughout the therapy, the toxic effects in all patients were negligible, and 75% of them had an objective locoregional reduction of disease. In only 2 cases was progression of disease observed within the irradiated area. On the basis of these data, it can be concluded that cisplatin at a level of 110 microg/l in the ultrafiltered plasma, in the reported scheme of continuous intravenous infusion, has an enhancing effect on radiation and avoids concentration peaks of platinum not bound to protein.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s004320050131", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1313647", 
        "issn": [
          "0171-5216", 
          "1432-1335"
        ], 
        "name": "Journal of Cancer Research and Clinical Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "124"
      }
    ], 
    "name": "cis-Diamminedichloroplatinum(II) given in low-dose continuous infusion with concurrent radiotherapy to patients affected by inoperable lung carcinoma: a pharmacokinetic approach", 
    "pagination": "37-43", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "dc3b90a570e3483c7f006a30fbc3139798e01be9da5d4ea55e88ea7571002cbb"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "9498833"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7902060"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s004320050131"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1046233188"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s004320050131", 
      "https://app.dimensions.ai/details/publication/pub.1046233188"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T21:32", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8687_00000491.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s004320050131"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s004320050131'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s004320050131'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s004320050131'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s004320050131'


 

This table displays all metadata directly associated to this object as RDF triples.

177 TRIPLES      20 PREDICATES      40 URIs      32 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s004320050131 schema:about N1e3a10bf258547cc84694b216ed9a48c
2 N2346c1e6cf5843929568ab4c42d369e4
3 N400ff784df1b43518f19480deb8df4c8
4 N62fbd4da5f26418d90e5fc978744a606
5 N673a34fa695f40c581d9c188a0533e18
6 N68efcba576b3476191454c82f263e4be
7 N8c8ca7d891f349f996054d68b19aa61b
8 N8e1abb90f83549a7a481bd29eafea368
9 Nce90159d0e114f70b31310298cfe5bef
10 Nd08ce9c0b1a94941af368563f88deab1
11 Nf33117c1c7774960948a81ab235f6d49
12 anzsrc-for:02
13 anzsrc-for:0202
14 schema:author Nd8575041f4784ebbadcbc1cf28538e40
15 schema:datePublished 1998-02
16 schema:datePublishedReg 1998-02-01
17 schema:description The pharmacokinetics of cis-diamminedichloro platinum(II) (cisplatin), given as a continuous infusion with concurrent radiotherapy to patients with locally advanced inoperable non-small-cell lung carcinoma, was investigated in 16 cases. The regimen, repeated for 6 consecutive weeks, consisted of weekly 10-Gy radiotherapy given in five fractions from Monday to Friday, and concurrent 100-h infusion of cisplatin delivered at a daily dose of 4 mg/m2 by a central venous catheter and a portable pump. Throughout the weeks of therapy the platinum levels were determined in plasma and in ultrafiltered plasma by respectively inductively coupled plasma atomic emission spectrometry and inductively coupled plasma mass spectrometry. Mean levels of platinum in plasma ([Pt]tot ) increased from the 1st to the 6th week of infusion, while mean levels of platinum in ultrafiltered plasma ([Pt]uf), 110 microg/l, showed no marked variation throughout the therapy. [Pt]uf ranged from 16% to 22% of the total Pt. Mean levels of Pt in ultrafiltered plasma were of the same order of magnitude as those found to be active in vitro as radiopotentiators. Pt decay levels were measured for 24 h at the end of the 1st and 5th weeks of infusion, allowing the calculation of the Pt half-life and the area under the decay curves. The mean value of the area under the decay curve, plotting [Pt]tot against time (AUC), in the range 0-24 h from the end of the 5th week of infusion, was about twice that from the end of the 1st week; by contrast, the mean AUC values did not vary for the [Pt]uf against time curves. The mean values of the alpha half-life of Pt in the ultrafiltered plasma were in accordance with those published in the literature; however, an unexpected very long beta half-life was found (more than 100 h). Thus it was suggested that Pt species other than free cisplatin were present in the ultrafiltered plasma; such species probably involve metal bound to low-molecular-mass proteins. Throughout the therapy, the toxic effects in all patients were negligible, and 75% of them had an objective locoregional reduction of disease. In only 2 cases was progression of disease observed within the irradiated area. On the basis of these data, it can be concluded that cisplatin at a level of 110 microg/l in the ultrafiltered plasma, in the reported scheme of continuous intravenous infusion, has an enhancing effect on radiation and avoids concentration peaks of platinum not bound to protein.
18 schema:genre research_article
19 schema:inLanguage en
20 schema:isAccessibleForFree false
21 schema:isPartOf N8ee89c7a724c4e41a0c20f7c82f48a5a
22 Neef9ca786b1c41e689d1c2c034b54ae4
23 sg:journal.1313647
24 schema:name cis-Diamminedichloroplatinum(II) given in low-dose continuous infusion with concurrent radiotherapy to patients affected by inoperable lung carcinoma: a pharmacokinetic approach
25 schema:pagination 37-43
26 schema:productId N29996cedf6b845ec90c82ddc28199018
27 N2b7c35bd4dfc4a7ea2cfa5d970de7dd1
28 N46596f9a965241c3b88b3f98994999ad
29 N9d6851f8d0634a82b3b136d7c6b21ad4
30 Nb8a1f9bb8dc74a088025c4621415309b
31 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046233188
32 https://doi.org/10.1007/s004320050131
33 schema:sdDatePublished 2019-04-10T21:32
34 schema:sdLicense https://scigraph.springernature.com/explorer/license/
35 schema:sdPublisher N2a7dbb641daa4ebdb99553d73ea553cc
36 schema:url http://link.springer.com/10.1007/s004320050131
37 sgo:license sg:explorer/license/
38 sgo:sdDataset articles
39 rdf:type schema:ScholarlyArticle
40 N03cdbf9ec38f4e1f8f1f420666d7a5cc rdf:first sg:person.01247677103.36
41 rdf:rest N3eacdb50dc8942209de73b1c2c217058
42 N136236c4c37c436cbde2d9fec3a71b7f rdf:first sg:person.0652707500.73
43 rdf:rest Nab2d122eea674245954dee437d8b5f2f
44 N1e3a10bf258547cc84694b216ed9a48c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
45 schema:name Combined Modality Therapy
46 rdf:type schema:DefinedTerm
47 N2346c1e6cf5843929568ab4c42d369e4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
48 schema:name Carcinoma, Non-Small-Cell Lung
49 rdf:type schema:DefinedTerm
50 N29996cedf6b845ec90c82ddc28199018 schema:name nlm_unique_id
51 schema:value 7902060
52 rdf:type schema:PropertyValue
53 N2a7dbb641daa4ebdb99553d73ea553cc schema:name Springer Nature - SN SciGraph project
54 rdf:type schema:Organization
55 N2b7c35bd4dfc4a7ea2cfa5d970de7dd1 schema:name readcube_id
56 schema:value dc3b90a570e3483c7f006a30fbc3139798e01be9da5d4ea55e88ea7571002cbb
57 rdf:type schema:PropertyValue
58 N3eacdb50dc8942209de73b1c2c217058 rdf:first sg:person.01065335303.03
59 rdf:rest N136236c4c37c436cbde2d9fec3a71b7f
60 N400ff784df1b43518f19480deb8df4c8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
61 schema:name Humans
62 rdf:type schema:DefinedTerm
63 N46596f9a965241c3b88b3f98994999ad schema:name dimensions_id
64 schema:value pub.1046233188
65 rdf:type schema:PropertyValue
66 N597d7aaf57ff408caea04aebbd003073 rdf:first sg:person.0720105551.12
67 rdf:rest N830c484399454440886c2003bbad252f
68 N5bd55fc217464a18ab243a7917328585 rdf:first sg:person.01035226740.01
69 rdf:rest rdf:nil
70 N62fbd4da5f26418d90e5fc978744a606 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Antineoplastic Agents
72 rdf:type schema:DefinedTerm
73 N673a34fa695f40c581d9c188a0533e18 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Adult
75 rdf:type schema:DefinedTerm
76 N68efcba576b3476191454c82f263e4be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Aged
78 rdf:type schema:DefinedTerm
79 N830c484399454440886c2003bbad252f rdf:first sg:person.01067474735.12
80 rdf:rest N03cdbf9ec38f4e1f8f1f420666d7a5cc
81 N844b90dd8c78400983c380f18be4f1fd rdf:first sg:person.0751665324.55
82 rdf:rest N597d7aaf57ff408caea04aebbd003073
83 N8c8ca7d891f349f996054d68b19aa61b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Cisplatin
85 rdf:type schema:DefinedTerm
86 N8e1abb90f83549a7a481bd29eafea368 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Lung Neoplasms
88 rdf:type schema:DefinedTerm
89 N8ee89c7a724c4e41a0c20f7c82f48a5a schema:volumeNumber 124
90 rdf:type schema:PublicationVolume
91 N9d6851f8d0634a82b3b136d7c6b21ad4 schema:name pubmed_id
92 schema:value 9498833
93 rdf:type schema:PropertyValue
94 Nab2d122eea674245954dee437d8b5f2f rdf:first Nce1bc9b9630844e09a2e62a53d2004fe
95 rdf:rest N5bd55fc217464a18ab243a7917328585
96 Nb8a1f9bb8dc74a088025c4621415309b schema:name doi
97 schema:value 10.1007/s004320050131
98 rdf:type schema:PropertyValue
99 Nce1bc9b9630844e09a2e62a53d2004fe schema:affiliation https://www.grid.ac/institutes/grid.4708.b
100 schema:familyName Masoni
101 schema:givenName Enrico
102 rdf:type schema:Person
103 Nce90159d0e114f70b31310298cfe5bef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Middle Aged
105 rdf:type schema:DefinedTerm
106 Nd08ce9c0b1a94941af368563f88deab1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Female
108 rdf:type schema:DefinedTerm
109 Nd8575041f4784ebbadcbc1cf28538e40 rdf:first sg:person.01255100453.07
110 rdf:rest N844b90dd8c78400983c380f18be4f1fd
111 Neef9ca786b1c41e689d1c2c034b54ae4 schema:issueNumber 1
112 rdf:type schema:PublicationIssue
113 Nf33117c1c7774960948a81ab235f6d49 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Male
115 rdf:type schema:DefinedTerm
116 anzsrc-for:02 schema:inDefinedTermSet anzsrc-for:
117 schema:name Physical Sciences
118 rdf:type schema:DefinedTerm
119 anzsrc-for:0202 schema:inDefinedTermSet anzsrc-for:
120 schema:name Atomic, Molecular, Nuclear, Particle and Plasma Physics
121 rdf:type schema:DefinedTerm
122 sg:journal.1313647 schema:issn 0171-5216
123 1432-1335
124 schema:name Journal of Cancer Research and Clinical Oncology
125 rdf:type schema:Periodical
126 sg:person.01035226740.01 schema:affiliation https://www.grid.ac/institutes/grid.417893.0
127 schema:familyName Bedini
128 schema:givenName Amedeo Vittorio
129 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01035226740.01
130 rdf:type schema:Person
131 sg:person.01065335303.03 schema:affiliation https://www.grid.ac/institutes/grid.416651.1
132 schema:familyName Petrucci
133 schema:givenName Francesco
134 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01065335303.03
135 rdf:type schema:Person
136 sg:person.01067474735.12 schema:affiliation https://www.grid.ac/institutes/grid.416651.1
137 schema:familyName Caroli
138 schema:givenName Sergio
139 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067474735.12
140 rdf:type schema:Person
141 sg:person.01247677103.36 schema:affiliation https://www.grid.ac/institutes/grid.416651.1
142 schema:familyName Alimonti
143 schema:givenName Alessandro
144 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247677103.36
145 rdf:type schema:Person
146 sg:person.01255100453.07 schema:affiliation https://www.grid.ac/institutes/grid.4708.b
147 schema:familyName Morazzoni
148 schema:givenName Franca
149 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255100453.07
150 rdf:type schema:Person
151 sg:person.0652707500.73 schema:affiliation https://www.grid.ac/institutes/grid.417893.0
152 schema:familyName Giudice
153 schema:givenName Gabriella
154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652707500.73
155 rdf:type schema:Person
156 sg:person.0720105551.12 schema:affiliation https://www.grid.ac/institutes/grid.4527.4
157 schema:familyName Zucchetti
158 schema:givenName Massimo
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720105551.12
160 rdf:type schema:Person
161 sg:person.0751665324.55 schema:affiliation https://www.grid.ac/institutes/grid.4708.b
162 schema:familyName Canevali
163 schema:givenName Carmen
164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751665324.55
165 rdf:type schema:Person
166 https://www.grid.ac/institutes/grid.416651.1 schema:alternateName Istituto Superiore di Sanità
167 schema:name Laboratorio di Tossicologia Applicata, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Roma, Italy, IT
168 rdf:type schema:Organization
169 https://www.grid.ac/institutes/grid.417893.0 schema:alternateName Istituto Nazionale dei Tumori
170 schema:name Istituto Nazionale Tumori, Via Venezian 1, 20133 Milano, Italy, IT
171 rdf:type schema:Organization
172 https://www.grid.ac/institutes/grid.4527.4 schema:alternateName Mario Negri Institute for Pharmacological Research
173 schema:name Istituto di Ricerche Farmacologiche “Mario Negri”, Via Eritrea 62, 20157 Milano, Italy, IT
174 rdf:type schema:Organization
175 https://www.grid.ac/institutes/grid.4708.b schema:alternateName University of Milan
176 schema:name Dipartimento di Scienza dei Materiali, Università di Milano, Via Emanueli 15, 20126 Milano, Italy, IT
177 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...